Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Enhertu
Enhertu
Surprise Enhertu rejection follows NICE process change
Pharmaphorum
Tue, 03/5/24 - 11:35 am
AstraZeneca
Daiichi Sankyo
HER2-low breast cancer
Enhertu
NICE
UK
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
Daiichi Sankyo again dials up Enhertu sales forecast, advances 2nd AstraZeneca-partnered ADC
Fierce Pharma
Wed, 01/31/24 - 10:27 pm
Daiichi Sankyo
AstraZeneca
Enhertu
earnings
AstraZeneca, Daiichi aim for first pan-tumor ADC approval
BioPharma Dive
Mon, 01/29/24 - 11:25 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
pan-tumor
FDA
Seagen patent in Daiichi Sankyo ADC dispute nixed by USPTO News
Pharmaphorum
Wed, 01/17/24 - 09:38 am
Seagen
Daiichi Sankyo
patents
legal
Enhertu
USPTO
ESMO: AstraZeneca-Daiichi get clarity on patient deaths for Enhertu follow up Dato-DXd, survival data still unclear
Fierce Biotech
Mon, 10/23/23 - 05:22 pm
ESMO
Daiichi Sankyo
AstraZeneca
Enhertu
patient deaths
clinical trials
non-small cell lung cancer
Seagen wins future royalties in Enhertu patent dispute
Pharmaphorum
Wed, 10/18/23 - 10:07 am
Seagen
Daiichi Sankyo
breast cancer
Enhertu
drug royalties
Enhertu offers survival benefits in Phase II solid tumour trial
Clinical Trials Arena
Sat, 07/29/23 - 10:42 pm
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
solid tumors
AstraZeneca stock slides as pivotal lung cancer readout on Daiichi-partnered ADC spooks investors
Fierce Biotech
Mon, 07/3/23 - 11:40 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
clinical trials
non-small cell lung cancer
AstraZeneca study points to new uses for targeted cancer drug Enhertu
BioPharma Dive
Mon, 06/5/23 - 11:32 am
ASCO 2023
AstraZeneca
Enhertu
uterine cancer
cervical cancer
ovarian cancer
bladder cancer
AstraZeneca, Daiichi Sankyo tease new Enhertu data — but details remain under wraps
Endpoints
Mon, 03/6/23 - 11:27 pm
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
The first big test for the son of Enhertu
EP Vantage
Fri, 01/20/23 - 10:17 am
Daiichi Sankyo
Enhertu
datopotamab deruxtecan
clinical trials
SABCS: AZ writes the 'next chapter' in Enhertu's saga with head-to-head win versus Roche's Kadcyla
Fierce Pharma
Fri, 12/9/22 - 10:54 am
SABCS
AstraZeneca
Enhertu
breast cancer
Daiichi Sankyo
Roche
Kadcyla
The problem with Her2-low testing
EP Vantage
Mon, 11/28/22 - 07:34 pm
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
diagnostics
HER2-low breast cancer
Daiichi Sankyo sets new highs for AstraZeneca-partnered cancer drug Enhertu
Endpoints
Mon, 10/31/22 - 04:15 pm
Daiichi Sankyo
AstraZeneca
Enhertu
breast cancer
non-small cell lung cancer
Roche nets FDA approval for HER2-low breast cancer test paired with AstraZeneca-Daiichi's Enhertu
Fierce Biotech
Wed, 10/5/22 - 07:07 pm
Roche
FDA
diagnostics
Medtech
HER2-low breast cancer
Enhertu
AstraZeneca
Daiichi Sankyo
FDA approves AstraZeneca, Daiichi drug in breast cancer first
BioPharma Dive
Sun, 08/7/22 - 11:24 pm
AstraZeneca
Daiichi Sankyo
breast cancer
Enhertu
FDA
HER2-low breast cancer
AstraZeneca wins two recommendations, one priority review
Morningstar
Mon, 07/25/22 - 10:54 am
AstraZeneca
Europe
Daiichi Sankyo
Enhertu
breast cancer
Ultomiris
Tezspire
Daiichi Sankyo willfully infringed Seagen patent in creating Enhertu, court rules
Fierce Pharma
Wed, 07/20/22 - 09:58 am
Daiichi Sankyo
Seagen
Enhertu
patents
legal
This Cancer Drug's News Could Mean Another Blockbuster for AstraZeneca
Motley Fool
Tue, 06/14/22 - 11:42 am
AstraZeneca
breast cancer
Enhertu
Pages
1
2
3
next ›
last »